BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3063335)

  • 1. A prospective randomized double-blind crossover study comparing the antiemetic activity of alizapride and metoclopramide in patients receiving cisplatin chemotherapy.
    Basurto C; Roila F; Del Favero A; Ballatori E; Minotti V; Tonato M
    Cancer Invest; 1988; 6(5):475-9. PubMed ID: 3063335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antiemetic activity of high-dose alizapride and high-dose metoclopramide in patients receiving cancer chemotherapy: a prospective, randomized, double-blind trial.
    Joss RA; Galeazzi RL; Bischoff AK; Pirovino M; Ryssel HJ; Brunner KW
    Clin Pharmacol Ther; 1986 Jun; 39(6):619-24. PubMed ID: 3519041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-emetic effect of high-dose metoclopramide vs alizapride--a randomised crossover study.
    Seng KT; Tiong CE; Hiang TC
    Br J Clin Pharmacol; 1994 Sep; 38(3):282-4. PubMed ID: 7826833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High doses of methylprednisolone with or without alizapride in the prevention of cisplatin-induced emesis. A randomized, double-blind, crossover study.
    Giaccone G; Bertetto O; Secat MA; Calciati A
    Oncology; 1988; 45(2):74-8. PubMed ID: 3353076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiemetic activity of high-dose metoclopramide and high-dose alizapride in combination with lorazepam in patients receiving cancer chemotherapy. A prospective, randomized, double-blind study.
    Molino A; Guglielmo L; Azzolini ME; Biondani P; Capelli MC; Grandinetti A; Griso C; Martinelli G; Martini N; Zanotti R
    Oncology; 1991; 48(2):111-5. PubMed ID: 1997932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Control of the emesis induced by cisplatin in patients with head and neck neoplasms. Randomized study of metoclopramide alizapride and placebo].
    Denaro A; Rossi M; Garozzo A; Matera M; Neri V
    G Ital Oncol; 1990; 10(1-2):29-34. PubMed ID: 2192985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose alizapride versus high-dose domperidone: a double-blind comparative study in the management of cis-platinum-induced emesis.
    Huys J; Troch M; Bourguignon RP; Smets P
    Curr Med Res Opin; 1985; 9(6):400-6. PubMed ID: 3886305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial.
    Gebbia V; Testa A; Valenza R; Cannata G; Tirrito ML; Gebbia N
    Cancer; 1995 Nov; 76(10):1821-8. PubMed ID: 8625054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of a new antiemetic agent: alizapride. A randomized double-blind crossover controlled trial.
    Bleiberg H; Gerard B; Dalesio O; Crespeigne N; Rozencweig M
    Cancer Chemother Pharmacol; 1988; 22(4):316-20. PubMed ID: 3048762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiemetic efficacy of alprazolam in the combination of metoclopramide plus methylprednisolone. Double-blind randomized crossover study in patients with cisplatin-induced emesis.
    Mori K; Saito Y; Tominaga K
    Am J Clin Oncol; 1993 Aug; 16(4):338-41. PubMed ID: 8392288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiemetic activity of high-dose metoclopramide combined with methylprednisolone versus metoclopramide alone in dacarbazine-treated cancer patients. A randomized double-blind study of the Italian Oncology Group for Clinical Research.
    Basurto C; Roila F; Tonato M; Ballatori E; Buzzi F; Calabresi F; Del Favero A
    Am J Clin Oncol; 1989 Jun; 12(3):235-8. PubMed ID: 2729180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin.
    Kris MG; Gralla RJ; Tyson LB; Clark RA; Cirrincione C; Groshen S
    J Clin Oncol; 1989 Jan; 7(1):108-14. PubMed ID: 2642536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial for the control of acute vomiting in cisplatin-treated patients: high-dose metoclopramide with dexamethasone and lorazepam as adjuncts versus high-dose alizapride plus dexamethasone and lorazepam. Study of the incidence of delayed emesis.
    Moreno I; Rosell R; Abad-Esteve A; Barnadas A; Carles J; Ribelles N
    Oncology; 1991; 48(5):397-402. PubMed ID: 1745488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research.
    Roila F; Tonato M; Basurto C; Picciafuoco M; Bracarda S; Donati D; Malacarne P; Monici L; Di Costanzo F; Patoia L
    J Clin Oncol; 1989 Nov; 7(11):1693-700. PubMed ID: 2681556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiemetic activity of high doses of metoclopramide combined with methylprednisolone versus metoclopramide alone in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research.
    Roila F; Tonato M; Basurto C; Bella M; Passalacqua R; Morsia D; DiCostanzo F; Donati D; Ballatori E; Tognoni G
    J Clin Oncol; 1987 Jan; 5(1):141-9. PubMed ID: 3543234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose intravenous metoclopramide versus combination high-dose metoclopramide and intravenous dexamethasone in preventing cisplatin-induced nausea and emesis: a single-blind crossover comparison of antiemetic efficacy.
    Strum SB; McDermed JE; Liponi DF
    J Clin Oncol; 1985 Feb; 3(2):245-51. PubMed ID: 4038511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phase I study of alizapride in cancer patients treated with cisplatin].
    Nicaise C; Rozencweig M; Ortmans M; Frisque C; Bleiberg H
    Sem Hop; 1983 Sep; 59(31):2161-5. PubMed ID: 6312589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized crossover antiemetic study in cisplatin-treated patients. Comparison between high-dose i.v. metoclopramide and high-dose i.v. dexamethasone.
    Frustaci S; Grattoni E; Tumolo S; Crivellari D; Figoli F; Galligioni E; Veronesi A; Tirelli U; Grigoletto E
    Cancer Chemother Pharmacol; 1986; 17(1):75-9. PubMed ID: 3698180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alizapride in a double-blind trial with metoclopramide in nausea and vomiting caused by radiotherapy].
    Budach V; Krüger K
    Fortschr Med; 1983 Oct; 101(39):1792-4. PubMed ID: 6642386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial comparing alizapride alone or with dexamethasone vs a metoclopramide-dexamethasone combination for emesis induced by moderate-dose cisplatin.
    Pollera CF; Nardi M; Marolla P; Carlini P
    Cancer Chemother Pharmacol; 1987; 19(4):335-8. PubMed ID: 3297376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.